The efficacy of a delayed release preparation of metformin (‘Obin’)† has been evaluated in 60 diabetic patients either obese and uncontrolled by diet alone or true primary or secondary failures to sulphonylurea treatment. The results show no difference in the therapeutic response between single and twice daily administration of ‘Obin’; likewise there was no difference in frequency of side-effects.
Get full access to this article
View all access options for this article.
References
1.
ClarkeB FDuncanL J P (1965) Combined metformin-chlorpropamide therapy in 108 diabetic sulphonylurea-failures. Lancet1, 1248.
2.
ClarkeB FDuncanL J P (1968) Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics. Lancet1, 123.
3.
ClarkeB FMarshallAMcGillR CMcCuishA CDuncanL J P (1967) A 3-year evaluation of combined sulphonylurea-metformin treatment in 200 diabetic ketoacidosis resistant sulphonylurea failures: In ‘Tolbutamide—After Ten Years‘. Excerpta Medica, New York, p. 312.
4.
SadowH S (1969) This question of lactic acidosis. Postgraduate medical Journal. 45, May Suppl, p 30.
5.
TranquadaR EBernsteinSMartinH E (1963) Irreversible lactic acidosis associated with phenformin therapy. Report of three cases. Journal of the American Medical Association. 184, 159.
6.
WellerCLinderM (1961) Continuous blood glucose measurements in diabetics given phenformin timed-disintegration capsules. Metabolism10, 669.
